Drug Markets/Selegiline

Selegiline

3 NDCs across 1 manufacturer|0 Generic,3 Brand

Selegiline is used to treat alzheimer disease, attention deficit disorder with hyperactivity, depressive disorder, parkinson disease and schizophrenia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Feb 27, 2006. In 2024, Medicare Part D spent $13 million on Selegiline across 5,355 claims for 866 beneficiaries.

Selegiline is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $75.00 to $75.43 per EAa 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

0G / 3B

Manufacturers

1

competing in market

Price Spread

$75.00 – $75.43

per EA

7d Activity

2-1 flat

avg +0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing SELEGILINE

Drug Portfolio

3 NDCs total, 3 shown

Frequently Asked Questions

What is Selegiline used to treat?

Selegiline is used to treat alzheimer disease, attention deficit disorder with hyperactivity, depressive disorder, parkinson disease and schizophrenia, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Selegiline?

In 2024, Medicare Part D spent $13 million on Selegiline across 5,355 claims for 866 beneficiaries.

How many Selegiline products are on the market?

The Selegiline drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.

What is the price range for Selegiline?

NADAC reference prices for Selegiline range from $74.9963 to $75.4269 per EA — a 1% difference between cheapest and most expensive.

Which manufacturers make Selegiline?

1 manufacturer lists Selegiline in NADAC. Ranked by number of NDCs, the largest are Viatris Specialty LLC (3).

How has the price of Selegiline changed recently?

Over the past 7 days, 2 Selegiline NDCs rose and 0 fell, with a market-wide average change of +0.0%.